Fluticasone propionate aerosol combined with ACEI/ARB reduces proteinuria in Immunoglobulin A nephropathy
China: According to a study published in BMC Nephrology, researchers have concluded that Fluticasone propionate aerosol combined with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) can reduce proteinuria levels in managing Immunoglobulin A nephropathy. They also mentioned that it has no significant effects on renal function.
In this study entitled “The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy”, Liping Sun provided detailed findings on the background.
The most common primary glomerulopathy worldwide is IgAN. There needs to be more data on the availability of effective treatment for this condition and requires more research in this context.
Researchers investigated the clinical efficacy of fluticasone propionate aerosol combined with ACEI/ARB in IgAN management on 142 patients who were divided randomly into two groups, namely supportive care plus fluticasone group (fluticasone propionate aerosol combined with ACEI/ARB) and the supportive care group(treated with ACEI/AR). The patients were followed up at 3, 6 and 9 months, and changes in proteinuria and estimated glomerular filtration rate (eGFR) were the primary outcomes.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.